EUVIMEDOpdag EUVIMED
Crossref

Tauroursodeoxycholic acid (TUDCA) ameliorates age‐related skeletal muscle loss

Marina S Carvalho iD, Leticia Barssotti, Lohanna M B Dos Santos iD, Lucas R O Rosa, Maria Cristina C Gomes-Marcondes iD, Everardo M Carneiro, Helena C L Barbosa iD, Lucas Zangerolamo iD

The Journal of Physiology · 2026-06 · 604 (12) · 4795-4814

DOI: 10.1113/jp290683 ↗

At a glance

Journal article in The Journal of Physiology, published online on 2026-05-15. Written by Marina S Carvalho and 7 co-authors. Institution: Obesity and Comorbidities Research Center, Department of Structural and Functional Biology, University of Campinas, UNICAMP, Campinas, Sao Paulo, Bra…. Major MEDLINE topics: Taurochenodeoxycholic Acid, Muscle, Skeletal, Aging. Cited 2 times so far (Crossref); 104 references. Funded by: Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Ageing leads to changes in body composition, including increased adiposity and reduced skeletal muscle mass and force. The alterations in ageing skeletal muscle result from impaired proteostasis driven by factors such as chronic inflammation, hormonal changes and reduced nutrient absorption. Those age‐related changes in body composition and skeletal muscle compromise mobility and increase the risk of falls, fractures and metabolic disorders. Tauroursodeoxycholic acid (TUDCA), a bile acid with known benefits in chronic diseases, has been shown by our group to improve cognition and metabolic homeostasis in ageing and Alzheimer's disease mouse models. Interestingly, in previous studies, TUDCA treatment was also associated with increased skeletal muscle mass in ageing mice, leading us to hypothesize that TUDCA could target skeletal muscle to reduce age‐related muscle loss. To explore this, we treated 18‐month‐old C57BL/6 mice with TUDCA or vehicle for 20 days, using 3‐month‐old mice as a young control group. We demonstrate that TUDCA treatment decreases body weight while increasing skeletal muscle mass, restores muscle fibre size and preserves functional integrity. Additionally, TUDCA enhances skeletal muscle insulin sensitivity through increased AKT activation and reduces tissue inflammation. Such improvements collectively support the restoration of skeletal muscle proteostasis, as indicated by increased protein synthesis and phosphorylation of key anabolic signalling pathways, including ribosomal protein S6 kinase beta‐1 (P70S6K) and eukaryotic translation initiation factor 4E‐binding protein 1 (4EBP1). These findings contribute to a better understanding of TUDCA's actions on skeletal muscles of ageing mice and highlight its role as a promising strategy against age‐related muscle loss. image Key points Tauroursodeoxycholic acid (TUDCA) treatment attenuates skeletal muscle loss in ageing mice. TUDCA improves skeletal muscle insulin sensitivity and restores AKT signalling. TUDCA exerts an anti‐inflammatory effect in skeletal muscle of ageing mice. TUDCA emerges as a potential therapy for age‐related skeletal muscle loss.

Subjects

MeSH terms (MEDLINE)

Taurochenodeoxycholic AcidMuscle, SkeletalAgingAnimalsMice, Inbred C57BLMiceMaleSarcopeniaProto-Oncogene Proteins c-akt

Author keywords

ageingageing‐related skeletal muscle lossbile acidsskeletal muscletauroursodeoxycholic acid

Substances

Taurochenodeoxycholic AcidursodoxicoltaurineProto-Oncogene Proteins c-akt

Authors and institutions

  • Obesity and Comorbidities Research Center, Department of Structural and Functional Biology, University of Campinas, UNICAMP, Campinas, Sao Paulo, Brazil.
  • Laboratory of Vascular Biology, Department of Structural and Functional Biology, University of Campinas, UNICAMP, Campinas, Sao Paulo, Brazil.
  • Laboratory of Nutrition and Cancer, Department of Structural and Functional Biology, University of Campinas, Campinas, Sao Paulo, Brazil.
  • Department of Pharmacology and Physiology, Université de Montréal, Faculty of Medicine, Montreal, Quebec, Canada.

ORCID profiles: Marina S Carvalho, Lohanna M B Dos Santos, Maria Cristina C Gomes-Marcondes, Helena C L Barbosa, Lucas Zangerolamo

Funding

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Cite

APA

Carvalho, M. S., Barssotti, L., Santos, L. M. B. D., Rosa, L. R. O., Gomes-Marcondes, M. C. C., Carneiro, E. M., Barbosa, H. C. L., & Zangerolamo, L. (2026). Tauroursodeoxycholic acid (TUDCA) ameliorates age‐related skeletal muscle loss. The Journal of Physiology, 604(12), 4795-4814. https://doi.org/10.1113/jp290683

Vancouver

Carvalho MS, Barssotti L, Santos LMBD, Rosa LRO, Gomes-Marcondes MCC, Carneiro EM, et al. Tauroursodeoxycholic acid (TUDCA) ameliorates age‐related skeletal muscle loss. The Journal of Physiology. 2026;604(12):4795-4814. doi:10.1113/jp290683

BibTeX
@article{Carvalho2026,
  author = {Carvalho, Marina S and Barssotti, Leticia and Santos, Lohanna M B Dos and Rosa, Lucas R O and Gomes-Marcondes, Maria Cristina C and Carneiro, Everardo M and Barbosa, Helena C L and Zangerolamo, Lucas},
  title = {Tauroursodeoxycholic acid (TUDCA) ameliorates age‐related skeletal muscle loss},
  journal = {The Journal of Physiology},
  year = {2026},
  volume = {604},
  number = {12},
  pages = {4795--4814},
  doi = {10.1113/jp290683}
}
Start for free →